XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues    
Total Revenues $ 1,441.6 $ 1,346.6
Expenses    
Compensation and benefits 204.5 185.2
Technology 51.3 45.9
Professional fees and outside services 38.3 31.8
Amortization of purchased intangibles 56.8 58.4
Depreciation and amortization 31.9 33.5
Licensing and other fee agreements 84.7 80.9
Other 60.4 51.8
Total Expenses 527.9 487.5
Operating Income 913.7 859.1
Non-Operating Income (Expense)    
Investment income 1,357.7 73.1
Interest and other borrowing costs (39.9) (42.5)
Equity in net earnings of unconsolidated subsidiaries 78.2 73.3
Other non-operating income (expense) (1,152.8) (46.7)
Total Non-Operating Income (Expense) 243.2 57.2
Income before Income Taxes 1,156.9 916.3
Income tax provision 273.1 205.3
Net Income 883.8 711.0
Net Income Attributable to Common Shareholders of CME Group $ 872.7 $ 702.0
Earnings per Share Attributable to Common Shareholders of CME Group:    
Basic (in dollars per share) $ 2.43 $ 1.96
Diluted (in dollars per share) $ 2.43 $ 1.95
Weighted Average Number of Common Shares:    
Basic (in shares) 358,933 358,609
Diluted (in shares) 359,313 359,180
Clearing and transaction fees [Member]    
Revenues    
Total Revenues $ 1,200.2 $ 1,138.1
Market data and information services    
Revenues    
Total Revenues 165.8 151.7
Other    
Revenues    
Total Revenues $ 75.6 $ 56.8